Closeup of a hand holding a model brain

Alzheimer’s Drug Development Pipeline: Promising Therapies, Pharma Investment Drive Momentum in Clinical Trials

Annual review of current Alzheimer’s clinical trials reveals trends in design, therapies, outcomes, and funding surrounding work to develop new treatments.

(Josh Hawkins/UNLV)

  • Research
  • May 25, 2023
  • By Tony Allen
  • Tony Allen (UNLV):; 702-895-0893

You Might Also Like